North Star Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Sell
2,965
-250
-8% -$22.9K 0.01% 311
2025
Q4
$289K Sell
3,215
-50
-2% -$4.74K 0.01% 291
2025
Q3
$322K Sell
3,265
-315
-9% -$31.2K 0.01% 273
2025
Q2
$327K Hold
3,580
0.01% 267
2025
Q1
$405K Buy
3,580
+417
+13% +$44.6K 0.02% 234
2024
Q4
$334K Buy
3,163
+180
+6% +$19.3K 0.01% 250
2024
Q3
$322K Hold
2,983
0.01% 254
2024
Q2
$324K Sell
2,983
-25
-0.8% -$2.95K 0.02% 251
2024
Q1
$397K Sell
3,008
-176
-6% -$22K 0.02% 234
2023
Q4
$387K Sell
3,184
-125
-4% -$13.9K 0.02% 232
2023
Q3
$371K Buy
3,309
+75
+2% +$9.52K 0.02% 231
2023
Q2
$471K Sell
3,234
-135
-4% -$18.3K 0.03% 214
2023
Q1
$435K Sell
3,369
-100
-3% -$12.6K 0.03% 222
2022
Q4
$442K Sell
3,469
-175
-5% -$20.3K 0.03% 214
2022
Q3
$381K Sell
3,644
-250
-6% -$27.4K 0.03% 215
2022
Q2
$409K Sell
3,894
-1,135
-23% -$135K 0.03% 210
2022
Q1
$643K Sell
5,029
-724
-13% -$87.3K 0.04% 188
2021
Q4
$710K Sell
5,753
-448
-7% -$58.6K 0.04% 190
2021
Q3
$881K Sell
6,201
-262
-4% -$38.5K 0.05% 168
2021
Q2
$1.01M Buy
6,463
+45
+0.7% +$7.29K 0.06% 156
2021
Q1
$997K Sell
6,418
-1,499
-19% -$232K 0.06% 155
2020
Q4
$1.18M Hold
7,917
0.07% 138
2020
Q3
$1.05M Sell
7,917
-180
-2% -$23.5K 0.08% 131
2020
Q2
$938K Sell
8,097
-51
-0.6% -$5.88K 0.07% 135
2020
Q1
$800K Sell
8,148
-1,993
-20% -$261K 0.08% 133
2019
Q4
$1.47M Sell
10,141
-361
-3% -$49.8K 0.11% 131
2019
Q3
$1.4M Sell
10,502
-1,602
-13% -$207K 0.11% 129
2019
Q2
$1.38M Sell
12,104
-774
-6% -$90.7K 0.11% 132
2019
Q1
$1.6M Sell
12,878
-500
-4% -$56.8K 0.13% 122
2018
Q4
$1.35M Sell
13,378
-2,180
-14% -$245K 0.13% 127
2018
Q3
$1.99M Sell
15,558
-3,070
-16% -$365K 0.16% 120
2018
Q2
$2.02M Sell
18,628
-2,590
-12% -$282K 0.17% 111
2018
Q1
$2.25M Sell
21,218
-3,239
-13% -$376K 0.2% 105
2017
Q4
$2.87M Sell
24,457
-1,061
-4% -$120K 0.26% 103
2017
Q3
$2.9M Sell
25,518
-6,724
-21% -$776K 0.29% 96
2017
Q2
$4.02M Sell
32,242
-14,315
-31% -$1.7M 0.41% 82
2017
Q1
$5.52M Buy
46,557
+1,133
+2% +$128K 0.58% 69
2016
Q4
$4.55M Buy
45,424
+32,913
+263% +$3.53M 0.5% 74
2016
Q3
$1.58M Sell
12,511
-979
-7% -$121K 0.18% 116
2016
Q2
$1.58M Sell
13,490
-1,107
-8% -$125K 0.18% 115
2016
Q1
$1.51M Sell
14,597
-541
-4% -$52.3K 0.18% 116
2015
Q4
$1.51M Sell
15,138
-747
-5% -$73.1K 0.18% 120
2015
Q3
$1.45M Hold
15,885
0.18% 124
2015
Q2
$1.69M Hold
15,885
0.19% 122
2015
Q1
$1.81M Sell
15,885
-798
-5% -$91K 0.21% 122
2014
Q4
$1.84M Sell
16,683
-592
-3% -$62.4K 0.21% 123
2014
Q3
$1.69M Sell
17,275
-618
-3% -$60.8K 0.2% 126
2014
Q2
$1.8M Sell
17,893
-83
-0.5% -$8.1K 0.21% 123
2014
Q1
$1.65M Sell
17,976
-1,099
-6% -$101K 0.2% 126
2013
Q4
$1.73M Sell
19,075
-84
-0.4% -$7.27K 0.21% 124
2013
Q3
$1.53M Sell
19,159
-876
-4% -$69K 0.2% 125
2013
Q2
$1.46M Buy
+20,035
New +$1.5M 0.2% 125

Other funds holding ZBH

North Star Asset Management's ZBH Position: Q1 2026 in Review

North Star Asset Management reduced its Zimmer Biomet (ZBH) stake by 7.8% in Q1 2026, selling an estimated $22.9K and leaving 2,965 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #311.

North Star Asset Management first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.52M in Q1 2017. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • North Star Asset Management held 2,965 shares of Zimmer Biomet worth $268K as of Q1 2026.
  • North Star Asset Management sold 250 Zimmer Biomet shares in Q1 2026, an estimated $22.9K.
  • Zimmer Biomet made up 0.01% of North Star Asset Management's portfolio in Q1 2026, its #311 holding.
  • North Star Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • North Star Asset Management's Zimmer Biomet position peaked at $5.52M in Q1 2017.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on North Star Asset Management's 13F filing for Q1 2026, filed 6 May 2026.